We know the people, products, and performance that show where the real impact is being made and where employers, investors, and investigators are wasting their time.
The best signals hide in patterns only insiders can read. ARSENAL was built for this.
AI synthesis is only as good as its inputs. ARSENAL is being built for that world.
One shows you what the FDA is about to decide. The other shows you which companies just became reachable, and why. Take either one free. The rest of the library comes with it.
Every pending FDA application with a published user fee goal date, filtered to genuinely open reviews and sorted by decision date.
Which biopharma companies moved this week, and what the movement says about when and how to approach them.